Showing results (101-110 of 192) with videos related to
Sort By:
Pageof 20
The Proceedings of the Nutrition Society|May 20, 2026
Culturally Adapted Multimodal Lifestyle Approaches for MASLD: Role of Diet, Physical Activity, and SleepElena S George, Surbhi Sood, Ayesha Sualeheen, et al.Journal of Gastrointestinal Cancer|September 9, 2020
SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)Ryan D Hirsch, Chris Mills, Rohit Sawhney, et al.Journal of Gastrointestinal Cancer|May 31, 2022
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysisGauri Mishra, Ammar Majeed, Anouk Dev, et al.Journal of Hepatology|November 28, 2012
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infectionMatthew T Kitson, Gregory J Dore, Jacob George, et al.Obesity Surgery|September 20, 2018
Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective StudyGeraldine J Ooi, Paul R Burton, Jacqueline Bayliss, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2016
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical TrialsZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2023
Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantageDaniel Clayton-Chubb, William W Kemp, Ammar Majeed, et al.Journal of Medical Case Reports|January 28, 2018
Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case reportShamil D Cooray, Neel M Heerasing, Laura A Selkrig, et al.Journal of Hepatology|July 13, 2010
Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosingWendy S C Cheng, Stuart K Roberts, Geoffrey McCaughan, et al.Antiviral Therapy|April 20, 2012
Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patientsDarrell H G Crawford, Gregory J Dore, William Sievert, et al.Pageof 20